Donna Shoupe

Summary

Affiliation: University of Southern California
Country: USA

Publications

  1. doi request reprint Individualizing hormone therapy to minimize risk: accurate assessment of risks and benefits
    Donna Shoupe
    Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
    Womens Health (Lond Engl) 7:475-85. 2011
  2. ncbi request reprint Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women
    Howard N Hodis
    Atherosclerosis Research Unit, Keck School of Medicine, Los Angeles, CA 90033, USA
    N Engl J Med 349:535-45. 2003
  3. ncbi request reprint Elevated subclinical atherosclerosis associated with oophorectomy is related to time since menopause rather than type of menopause
    Wendy J Mack
    Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA
    Fertil Steril 82:391-7. 2004
  4. ncbi request reprint Ovarian conservation at the time of hysterectomy for benign disease
    William H Parker
    UCLA School of Medicine, Los Angeles, California, USA
    Clin Obstet Gynecol 50:354-61. 2007
  5. ncbi request reprint Individualizing hormone-therapy according to cardiovascular risk
    D Shoupe
    Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Minerva Med 103:343-52. 2012
  6. ncbi request reprint Elective oophorectomy for benign gynecological disorders
    Donna Shoupe
    Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA
    Menopause 14:580-5. 2007
  7. ncbi request reprint Elective oophorectomy in the gynecological patient: when is it desirable?
    William H Parker
    UCLA School of Medicine, Los Angeles, California, USA
    Curr Opin Obstet Gynecol 19:350-4. 2007
  8. ncbi request reprint Ovarian conservation at the time of hysterectomy for benign disease
    William H Parker
    The David Geffen School of Medicine, University of California, Los Angeles, California, USA
    Obstet Gynecol 106:219-26. 2005
  9. ncbi request reprint Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial
    Anne Z Steiner
    Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA
    Menopause 12:728-33. 2005
  10. ncbi request reprint Unopposed estradiol therapy in postmenopausal women: results from two randomized trials
    Anne Z Steiner
    Department of Obstetrics and Gynecology, University of Southern California, Keck School of Medicine, Los Angeles, California 90033, USA
    Obstet Gynecol 109:581-7. 2007

Detail Information

Publications14

  1. doi request reprint Individualizing hormone therapy to minimize risk: accurate assessment of risks and benefits
    Donna Shoupe
    Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
    Womens Health (Lond Engl) 7:475-85. 2011
    ..Adjusting the dose of therapy and considering a transdermal approach, particularly in high-risk patients, are important considerations...
  2. ncbi request reprint Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women
    Howard N Hodis
    Atherosclerosis Research Unit, Keck School of Medicine, Los Angeles, CA 90033, USA
    N Engl J Med 349:535-45. 2003
    ..Whether 17beta-estradiol (the endogenous estrogen molecule) alone or administered sequentially with medroxyprogesterone acetate can slow the progression of atherosclerosis is unknown...
  3. ncbi request reprint Elevated subclinical atherosclerosis associated with oophorectomy is related to time since menopause rather than type of menopause
    Wendy J Mack
    Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA
    Fertil Steril 82:391-7. 2004
    ..To compare common carotid artery intima-media thickness (IMT) between women who had natural menopause with those who had surgical menopause and to correlate IMT with time since menopause...
  4. ncbi request reprint Ovarian conservation at the time of hysterectomy for benign disease
    William H Parker
    UCLA School of Medicine, Los Angeles, California, USA
    Clin Obstet Gynecol 50:354-61. 2007
    ..Therefore, the decision to perform prophylactic oophorectomy should be approached with great caution for the majority of women who are at low risk of developing ovarian cancer...
  5. ncbi request reprint Individualizing hormone-therapy according to cardiovascular risk
    D Shoupe
    Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Minerva Med 103:343-52. 2012
    ..However, special considerations are needed for women who are outside those boundaries or for those that have risk factors for cardiovascular disease...
  6. ncbi request reprint Elective oophorectomy for benign gynecological disorders
    Donna Shoupe
    Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA
    Menopause 14:580-5. 2007
    ..To review the risks and benefits of elective oophorectomy and to make a clinical recommendation for an appropriate age when benefits of this procedure outweigh the risks...
  7. ncbi request reprint Elective oophorectomy in the gynecological patient: when is it desirable?
    William H Parker
    UCLA School of Medicine, Los Angeles, California, USA
    Curr Opin Obstet Gynecol 19:350-4. 2007
    ..Oophorectomy is electively performed in approximately 300,000 US women per year who are having hysterectomy for benign disease...
  8. ncbi request reprint Ovarian conservation at the time of hysterectomy for benign disease
    William H Parker
    The David Geffen School of Medicine, University of California, Los Angeles, California, USA
    Obstet Gynecol 106:219-26. 2005
    ..Prophylactic oophorectomy is often recommended concurrent with hysterectomy for benign disease. The optimal age for this recommendation in women at average risk for ovarian cancer has not been determined...
  9. ncbi request reprint Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial
    Anne Z Steiner
    Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA
    Menopause 12:728-33. 2005
    ..To determine if 17beta-estradiol increases blood pressure in postmenopausal women...
  10. ncbi request reprint Unopposed estradiol therapy in postmenopausal women: results from two randomized trials
    Anne Z Steiner
    Department of Obstetrics and Gynecology, University of Southern California, Keck School of Medicine, Los Angeles, California 90033, USA
    Obstet Gynecol 109:581-7. 2007
    ..To estimate the rates of endometrial hyperplasia, bleeding episodes, and interventions among menopausal women receiving unopposed oral estradiol or placebo therapy with ultrasound monitoring over 3 years...
  11. doi request reprint Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study
    William H Parker
    John Wayne Cancer Institute, Santa Monica, the Partnership for Health Analytic Research, LLC, Beverly Hills, The Keck School of Medicine at the University of Southern California, Los Angeles, USA
    Obstet Gynecol 121:709-16. 2013
    ....
  12. doi request reprint Effect of isoflavone soy protein supplementation on endometrial thickness, hyperplasia, and endometrial cancer risk in postmenopausal women: a randomized controlled trial
    Alexander M Quaas
    From the Departments of 1Ob Gyn and 2Preventive Medicine, 3Atherosclerosis Research Unit, and Departments of 4Medicine and 5Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA
    Menopause 20:840-4. 2013
    ..This study aims to determine whether long-term isoflavone soy protein (ISP) supplementation affects endometrial thickness and rates of endometrial hyperplasia and cancer in postmenopausal women...
  13. pmc Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial
    Howard N Hodis
    USC Keck School of Medicine, Atherosclerosis Research Unit, 2250 Alcazar Street, CSC132, Los Angeles, CA 90033, USA
    Stroke 42:3168-75. 2011
    ..We determined whether ISP reduces subclinical atherosclerosis assessed as carotid artery intima-media thickness progression...
  14. ncbi request reprint A short study in the treatment of hot flashes with buccal administration of 17-beta estradiol
    Margery S Gass
    Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine, Cincinnati, OH, USA
    Maturitas 49:140-7. 2004
    ..To assess the efficacy and safety of 17-beta estradiol buccal tablets in reducing hot flush frequency (HFF) in postmenopausal women...